TRANSFECTION AND OVEREXPRESSION OF THE HUMAN 60-KDA RO/SS-A AUTOANTIGEN IN HEP-2 CELLS

被引:52
|
作者
KEECH, CL
MCCLUSKEY, J
GORDON, TP
机构
[1] Centre for Transfusion Medicine and Immunology, Department of Clinical Immunology, Flinders Medical Centre, Bedford Park
来源
关键词
D O I
10.1006/clin.1994.1181
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A full-length cDNA encoding human 60-kDa Ro/SS-A protein was transfected into and overexpressed in the human cell line HEp-2, with the aim of developing an improved reagent for indirect immunofluorescence (IF) detection of anti-Ro autoantibodies. Stable transfectants were analyzed by IF using a panel of 20 precipitin-positive anti-Ro human sera. Transfectants showed bright finely speckled nuclear and nucleolar staining. No surface membrane expression was detected despite marked overexpression of 60-kDa Ro. All human anti-Ro sera reacted with the transfectants with titers ranging from 1:320 to 1:40,960. The same sera tested on untransfected cells showed titers from negative (3 sera) to 1:160. These transfectants dramatically increase the sensitivity of IF testing (mean increase in titer of 41-fold) and allow detection of specific anti-Ro antibodies in samples negative or equivocal on untransfected cells. The staining patterns of antisera of other important specificities remained unaltered. In a study of sera from 22 patients with systemic lupus erythematosus, anti-60-kDa Ro autoantibodies were detected in all sera when tested on 60-kDa Ro-transfected HEp-2 cells; however, in 12 of 22 sera autoantibodies were undetectable by recombinant 60-kDa Ro ELISA. The 60-kDa Ro transfectants are a simple and sensitive method for detection of anti-Ro antibodies in patients with systemic rheumatic diseases. (C) 1994 Academic Press, Inc.
引用
收藏
页码:146 / 151
页数:6
相关论文
共 50 条
  • [31] EXPRESSION OF THE HUMAN 46 KD RO/SS-A AUTOANTIGEN (CALRETICULIN) AS A RECOMBINANT PROTEIN
    ZAPPI, EG
    MCCAULIFFE, DP
    HASEMANN, CA
    LIEU, TS
    SONTHEIMER, RD
    CAPRA, JD
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (04) : 561 - 561
  • [32] CHARACTERIZATION OF THE PROMOTER REGION OF HUMAN CALRETICULIN (THE 46 KD RO/SS-A AUTOANTIGEN)
    MCCAULIFFE, DP
    YANG, YS
    SONTHEIMER, RD
    CAPRA, JD
    CLINICAL RESEARCH, 1991, 39 (02): : A491 - A491
  • [33] EXPRESSION OF THE HUMAN 46 KD RO SS-A AUTOANTIGEN (CALRETICULIN) AS A RECOMBINANT PROTEIN
    ZAPPI, EG
    MCCAULIFFE, DP
    HASEMANN, CA
    SONTHEIMER, RD
    CAPRA, JD
    FASEB JOURNAL, 1991, 5 (06): : A1634 - A1634
  • [34] EXPRESSION OF THE HUMAN 46 KD RO/SS-A AUTOANTIGEN (CALRETICULIN) AS A RECOMBINANT PROTEIN
    ZAPPI, EG
    MCCAULIFFE, DP
    HASEMANN, CA
    SONTHEIMER, RD
    CAPRA, JD
    CLINICAL RESEARCH, 1990, 38 (04): : A962 - A962
  • [35] 17-beta-estradiol increases expression of 52-kDa and 60-kDa SS-A/Ro autoantigens in human keratinocytes and breast cancer cell line MCF-7
    Wang, DR
    Chan, EKL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (04) : 610 - 614
  • [36] Anti-Ro(SS-A) 52 kDa and 60 kDa specificities in undifferentiated connective tissue disease
    Belfiore, N
    Rossi, S
    Bobbio-Pallavicini, F
    Epis, O
    Caporali, R
    Montecucco, C
    JOINT BONE SPINE, 2000, 67 (03) : 183 - 187
  • [37] Retropseudogenes derived from the human Ro/SS-A autoantigen-associated hY RNAs
    Perreault, J
    Noël, JF
    Brière, F
    Cousineau, B
    Lucier, JF
    Perreault, JP
    Boire, G
    NUCLEIC ACIDS RESEARCH, 2005, 33 (06) : 2032 - 2041
  • [38] Binding of the 60-kDa Ro autoantigen to Y RNAs: Evidence for recognition in the major groove of a conserved helix
    Green, CD
    Long, KS
    Shi, H
    Wolin, SL
    RNA, 1998, 4 (07) : 750 - 765
  • [39] ANTIBODIES (ABS) TO ONCHOCERCA-VOLVULUS CROSS-REACT WITH A HUMAN RO/SS-A (RO) AUTOANTIGEN (AAG)
    LUX, FA
    MCCAULIFFE, DP
    BUTTNER, DW
    CAPRA, JD
    SONTHEIMER, RD
    LIEU, TS
    CLINICAL RESEARCH, 1990, 38 (02): : A626 - A626
  • [40] Screening for autoantibodies to SS-A/Ro by indirect immunofluorescence using HEp-2000™ cells
    Bossuyt, X
    Meurs, L
    Mewis, A
    Mariën, G
    Blanckaert, N
    ANNALS OF CLINICAL BIOCHEMISTRY, 2000, 37 : 216 - 219